These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4094182)

  • 1. Effects of cholinergic drugs on aversive operant behavior induced by dorsal central gray stimulation in rats.
    Moriyama M; Ichimaru Y; Gomita Y; Fukuda T
    Jpn J Pharmacol; 1985 Nov; 39(3):339-47. PubMed ID: 4094182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of morphine on operant escape behavior and averse symptom induced by dorsal central gray stimulation in rats.
    Moriyama M; Gomita Y; Ichimaru Y; Araki Y
    Jpn J Pharmacol; 1991 Jan; 55(1):169-73. PubMed ID: 2041223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cholinergic agonists and antagonists on self-stimulation behavior in the rat.
    Newman LM
    J Comp Physiol Psychol; 1972 Jun; 79(3):394-413. PubMed ID: 5054476
    [No Abstract]   [Full Text] [Related]  

  • 4. Nicotine and arecoline as discriminative stimuli: involvement of a non-cholinergic mechanism for nicotine.
    Meltzer LT; Rosecrans JA
    Pharmacol Biochem Behav; 1988 Mar; 29(3):587-93. PubMed ID: 3362953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinergic drug effects on a delayed conditional discrimination task in the rat.
    Herremans AH; Hijzen TH; Olivier B; Slangen JL
    Behav Neurosci; 1995 Jun; 109(3):426-35. PubMed ID: 7662153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of physostigmine and scopolamine on operant brightness discrimination in the rat.
    Leaton RN; Kreindler M
    Physiol Behav; 1972 Jul; 9(1):121-3. PubMed ID: 5080149
    [No Abstract]   [Full Text] [Related]  

  • 7. Discriminative stimulus properties of physostigmine in rats.
    Tang AH; Franklin SR
    Eur J Pharmacol; 1988 Aug; 153(1):97-104. PubMed ID: 3215280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scopolamine-physostigmine combination does not substitute for nicotine.
    Schechter MD
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 May; 19(3):499-508. PubMed ID: 7624500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between scopolamine and muscarinic cholinergic agonists or cholinesterase inhibitors on spatial alternation performance in rats.
    Shannon HE; Bemis KG; Hendrix JC; Ward JS
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1071-7. PubMed ID: 2262893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of cholinergic drugs on delayed discrimination disruption by AF64A in rats].
    Miyata H; Hironaka N; Ando K
    Nihon Yakurigaku Zasshi; 1991 May; 97(5):259-66. PubMed ID: 1879804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cholinergic drugs on prey-killing by rodents.
    Wnek DJ; Leaf RC
    Physiol Behav; 1973 Jun; 10(6):1107-13. PubMed ID: 4736903
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of anxiolytic drugs on escape behavior induced by dorsal central gray stimulation in rats.
    Gomita Y; Moriyama M; Ichimaru Y; Araki Y
    Physiol Behav; 1991 Jan; 49(1):125-9. PubMed ID: 1673252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of central cholinergic pathways on performance on free-operant avoidance and DRL schedules.
    Kelsey JE; Grossman SP
    Pharmacol Biochem Behav; 1975; 3(6):1043-50. PubMed ID: 1223893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral suppression using intracranial reward and punishment: effects of benzodiazepines.
    Moriyama M; Ichimaru Y; Gomita Y
    Pharmacol Biochem Behav; 1984 Nov; 21(5):773-8. PubMed ID: 6151197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of the behavioral effects of aprophen, atropine and scopolamine to antagonism of the behavioral effects of physostigmine.
    Genovese RF; Elsmore TF; Witkin JM
    Pharmacol Biochem Behav; 1990 Sep; 37(1):117-22. PubMed ID: 2263653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminative stimulus properties of muscarinic agonists.
    Jung M; Costa L; Shearman GT; Kelly PH
    Psychopharmacology (Berl); 1987; 93(2):139-45. PubMed ID: 3122245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of agonists and antagonists of cholinergic receptors on self-stimulation of the medial prefrontal cortex of the rat.
    Vives F; Mora F
    Gen Pharmacol; 1986; 17(1):63-7. PubMed ID: 3949150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cholinergic agonists on the dorsal immobility response.
    Potter TJ; Cottrell GA; Van Hartesveldt C
    Pharmacol Biochem Behav; 1990 May; 36(1):77-80. PubMed ID: 2349272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neural systems activated by the aversive stimulation of dorsal central gray.
    Gomita Y; Moriyama M; Ichimaru Y; Araki Y
    Jpn J Pharmacol; 1988 Sep; 48(1):137-41. PubMed ID: 3199601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the aversive qualities of shock through a central inhibitory cholinergic system in the rat.
    Houser VP
    Pharmacol Biochem Behav; 1976 May; 4(5):561-8. PubMed ID: 951435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.